Sanofi's Genzyme pays $32.59 mln in criminal Seprafilm case
September 03, 2015 at 17:44 PM EDT
Sept 3 (Reuters) - Genzyme Corp, a unit of French drug company Sanofi SA, will pay $32.59 million and admit wrongdoing to resolve criminal charges over the unlawful distribution of the surgical device Seprafilm, the U.S. Department of Justice said on Thursday.
